Table 3.
Graft survival is similar in HCV-negative recipients of livers from HCV NAT-positive or -negative donors (Data from Cotter et al[40])
| 1-yr | 2-yr | |
| DNAT-/R- | 93% | 88% |
| DNAT-/R+ | 93% | 88% |
| DNAT+/R- | 93% | 86% |
| DNAT+/R+ | 94% | 90% |
DNAT: Donor HCV NAT status; R: Recipient HCV NAT status.